Economic evaluationCost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States
Under an Elsevier user license
open archive
Keywords
AIDS
cost-effectiveness analysis
drug combinations
Markov model
Cited by (0)
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.